Teijin Limited (TINLY)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Teijin Limited (TINLY) trades at $9.15. Teijin Limited is a global enterprise established in 1918, operating across advanced materials, healthcare, and information technology sectors. Market cap: $1.77B, Sector: Industrials.
Price live · AI analysis from Jun 14, 2026Analyst Coverage for TINLY: TINLY does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates TINLY against Industrials peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
TINLY: 1/1 perspectives are bearish.
How is this calculated? →Teijin Limited (TINLY) Industrial Operations Profile
Teijin Limited is a Tokyo-headquartered global enterprise specializing in high-performance materials, including aramid and carbon fibers, alongside comprehensive healthcare solutions and advanced IT offerings. This diversified portfolio positions the company across critical industrial, medical, and technological markets worldwide.
What Is the Investment Thesis for TINLY?
Teijin Limited presents a diversified investment profile driven by its extensive portfolio in high-performance materials, healthcare, and IT solutions. A key value driver is the growing global demand for lightweight materials, particularly carbon and aramid fibers, in sectors like automotive and aerospace, where Teijin holds established expertise. The company's healthcare segment, with its pharmaceuticals and medical devices, is poised to benefit from an aging global population and increasing healthcare needs. Despite a negative profit margin of -10.1%, the company maintains a gross margin of 18.5%, indicating efficiency in its core manufacturing processes. The 3.05% dividend yield offers income potential. However, as an OTC Other listed ADR with a market capitalization of $1.77B and a Beta of 0.30, investors face liquidity risks and exposure to global economic conditions and currency fluctuations. The company's commitment to sustainable materials and engineering solutions for global challenges represents a long-term growth catalyst, aligning with evolving market demands and regulatory pressures.
Based on FMP financials and quantitative analysis
TINLY Key Highlights
- Market Capitalization: Teijin Limited holds a market capitalization of $1.77B, positioning it as a mid-sized global industrial conglomerate.
- Profitability Challenge: The company reported a profit margin of -10.1%, indicating current operational challenges impacting overall net income.
- Gross Margin Performance: Teijin maintains a gross margin of 18.5%, reflecting its ability to manage production costs relative to revenue from its diverse product lines.
- Dividend Yield: Investors receive a dividend yield of 3.05%, providing an income component despite the company's recent profitability issues.
- Global Workforce: With 21,834 employees, Teijin Limited operates a significant global workforce supporting its extensive research, manufacturing, and service operations across multiple continents.
Who Are TINLY's Competitors?
TINLY is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| CRESY Cresud Sociedad Anónima, Comercial, Inmobiliaria, Financiera y Agropecuaria | $11.05 | +0.36% | $716.86M | 64 |
| RSDEF Ramsdens Holdings PLC | $2.39 | +0.00% | $78.15M | 59 |
| MPCFF Metro Pacific Investments Corporation | $0.05 | +0.00% | $1.43B | 58 |
| FIP FTAI Infrastructure Inc. | $4.43 | -0.23% | $523.46M | 57 |
| CODI Compass Diversified (CODI) | $10.26 | -3.30% | $771.92M | 48 |
| UMCN UMC, Inc. | $0.06 | -0.17% | $39.36M | 48 |
| KTERF Keio Corporation | $4.49 | +0.00% | $2.61B | 48 |
| AYYLF Ayala Corporation | $7.70 | +17.56% | $4.78B | 48 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are TINLY's Key Strengths?
- Highly diversified business portfolio across advanced materials, healthcare, and IT, providing resilience.
- Strong expertise and technological leadership in high-performance materials like aramid and carbon fibers.
- Global operational presence and an established brand with over a century of history.
- Commitment to addressing global challenges, aligning with sustainability and societal needs.
What Are TINLY's Weaknesses?
- Currently operating with a negative profit margin of -10.1%, indicating profitability challenges.
- OTC Other listing and ADR status may lead to lower liquidity and less visibility compared to major exchanges.
- Exposure to global economic conditions and currency exchange rate fluctuations due to international operations.
- Disclosure status on OTC market is unknown, potentially limiting investor access to comprehensive financial information.
What Could Drive TINLY Stock Higher?
- Development and commercialization of new high-performance materials tailored for emerging industrial applications, potentially expanding market reach and revenue streams.
- Launch of innovative pharmaceutical products or advanced medical devices that address significant unmet medical needs, driving growth in the healthcare segment.
- Increasing global adoption of sustainable materials and environmental engineering solutions, aligning Teijin with growing market demand for eco-friendly products and services.
- Expansion of Recopic RFID solutions into new manufacturing, logistics, or retail sectors, enhancing efficiency and inventory management for a broader client base.
What Are the Key Risks for TINLY?
- Financial-distress signal — its Altman Z-Score of 1.49 sits in the distress zone (elevated bankruptcy risk).
- Negative return on equity (-22.5%) — the business is not currently generating profit on shareholder capital.
- Global economic slowdowns or recessions could significantly impact demand for Teijin's industrial materials and potentially affect healthcare spending, leading to reduced revenues.
- Fluctuations in the JPY/USD exchange rate pose a continuous currency risk for ADR holders, potentially eroding the dollar value of dividends and the overall investment.
- Intense competition across Teijin's diverse segments, including advanced materials, pharmaceuticals, and IT, could pressure profit margins and market share.
- Regulatory changes in the healthcare sector, environmental standards, or international trade policies could increase compliance costs or restrict market access.
- The OTC Other listing presents inherent liquidity risks, potentially making it difficult for investors to buy or sell shares efficiently and contributing to price volatility.
What Are the Growth Opportunities for TINLY?
- Advanced Lightweight Materials for Automotive and Aerospace: Teijin's expertise in high-performance fibers like carbon and aramid, along with advanced composite solutions, positions it to capitalize on the increasing demand for lightweight materials. The global automotive lightweight materials market is projected to grow significantly, driven by stringent emission regulations and the shift towards electric vehicles. Teijin's glass and carbon fiber reinforced materials directly address the need for reduced vehicle weight, enhancing fuel efficiency and battery range, making this a substantial, ongoing growth driver.
- Expansion in Healthcare Solutions for Aging Populations: The global demographic trend of an aging population is a powerful catalyst for Teijin's healthcare segment. With offerings spanning pharmaceuticals for chronic conditions, home oxygen therapy, NPPV devices, and community-based integrated care systems, the company is well-aligned with this long-term societal shift. The market for medical devices and age-related pharmaceuticals is consistently expanding, providing a stable and growing revenue stream for Teijin's specialized healthcare technologies.
- Sustainable Materials and Environmental Engineering Solutions: Teijin's commitment to sustainable recycled polyester fibers and engineering solutions for environmental pollution and energy supply represents a significant growth opportunity. As global regulations tighten and corporate sustainability goals become more prevalent, demand for eco-friendly materials and technologies is surging. This includes solutions for circular economy initiatives and reducing carbon footprints, offering Teijin a pathway to expand its market share in environmentally conscious industries over the next decade.
- Digital Transformation through RFID and IT Solutions: The Recopic RFID solution for inventory management offered by Teijin's information technology segment addresses a critical need for efficiency and automation in manufacturing and logistics. As industries continue their digital transformation journeys, the adoption of advanced inventory tracking and supply chain optimization tools is accelerating. Teijin's specialized IT offerings can capture a growing share of this market, providing solutions that enhance operational productivity and reduce costs for industrial clients globally.
- Diversified Applications of High-Performance Films and Engineering Plastics: Beyond traditional uses, Teijin's wide range of films, sheets, and engineering plastics (like polycarbonate and polyphenylene sulfide resins) are critical components in various high-growth sectors. These materials find applications in electronics, renewable energy, and specialized industrial equipment, driven by innovation and performance requirements. The ongoing development of new applications and customization for specific industry needs presents a continuous opportunity for Teijin to expand its market reach and product utility.
What Opportunities Does TINLY Have?
- Growing global demand for lightweight materials in automotive and aerospace sectors driven by efficiency needs.
- Expansion of healthcare solutions fueled by an aging global population and increasing medical demands.
- Increasing adoption of sustainable materials and environmental engineering solutions across industries.
- Further penetration of IT solutions like RFID into industrial and logistics sectors for enhanced efficiency.
What Threats Does TINLY Face?
- Intense competition across its diverse segments, requiring continuous innovation and market adaptation.
- Adverse fluctuations in global economic conditions impacting demand for industrial materials and healthcare spending.
- Currency exchange rate volatility, particularly JPY/USD, affecting the value of ADRs and reported financials.
- Regulatory changes in the materials, healthcare, or environmental sectors that could impact operations and compliance costs.
What Are TINLY's Competitive Advantages?
- Proprietary Material Science Expertise: Extensive R&D and intellectual property in high-performance fibers, films, and engineering plastics, creating barriers to entry.
- Diversified Business Portfolio: Spanning materials, healthcare, and IT, which can provide resilience against downturns in any single sector and enable cross-segment synergies.
- Global Operational Footprint: A well-established global presence and supply chain facilitate access to diverse markets and customer bases.
- Long-standing Industry Presence: Founded in 1918, Teijin has over a century of experience, fostering deep industry relationships and brand recognition.
- Integrated Solutions Capability: Ability to offer comprehensive solutions, from raw materials to finished products and IT services, providing a competitive edge over specialized component suppliers.
What Does TINLY Do?
Teijin Limited, founded in 1918 and headquartered in Tokyo, Japan, has evolved into a diversified global enterprise with significant operations across advanced materials, healthcare, and information technology. Within its robust materials divisions, the company is a prominent manufacturer of specialized products. This includes high-performance fibers such as aramid and carbon fibers, recognized for their strength-to-weight ratio, alongside oxidized PAN fibers and various polyethylene-based materials. Teijin also produces a wide array of films and sheets, including polycarbonate, high-density polyethylene porous films, and general microporous films, catering to diverse industrial applications. Furthermore, its engineering plastics portfolio encompasses PC resins and polyphenylene sulfide resins, complete with molded components and additives. The company is at the forefront of advanced composite solutions, supplying lightweight glass and carbon fiber reinforced materials specifically engineered for automotive applications, contributing to fuel efficiency and reduced emissions. Complementing these, Teijin offers polytrimethylene terephthalate products, artificial leather, polyester nanofibers, and sustainable recycled polyester fibers, emphasizing environmental responsibility. In the healthcare segment, Teijin provides a comprehensive suite of solutions, including pharmaceuticals targeting bone and joint health, respiratory conditions, and cardiovascular and metabolic disorders. Its medical device offerings span home oxygen therapy equipment, non-invasive positive pressure ventilation (NPPV) devices, rehabilitation aids, and systems for sleep-disordered breathing. Innovative healthcare technologies also include a sonic accelerated fracture healing system and community-based integrated care systems, alongside orthopedic implantable devices and functional food ingredients. The information technology division features Recopic, an advanced radio-frequency identification (RFID) solution designed to optimize inventory management. Beyond specific products, Teijin is actively engaged in engineering solutions to address pressing global challenges such as environmental pollution, energy supply stability, and the societal impacts of an aging workforce, demonstrating a commitment to broader societal contributions.
What Products and Services Does TINLY Offer?
- Manufacture high-performance fibers such as aramid and carbon fibers for various industrial applications.
- Produce diverse films and sheets, including polycarbonate and high-density polyethylene porous films.
- Supply engineering plastics like PC resins and polyphenylene sulfide resins, along with molded components.
- Develop advanced composite solutions, including lightweight glass and carbon fiber reinforced materials for automotive.
- Offer pharmaceuticals for bone and joint health, respiratory, cardiovascular, and metabolic conditions.
- Provide medical devices such as home oxygen therapy equipment, NPPV devices, and rehabilitation aids.
- Develop and implement IT solutions, including Recopic, an RFID system for inventory management.
- Engage in engineering solutions to address global challenges like environmental pollution and energy supply.
How Does TINLY Make Money?
- Sales of advanced materials: Revenue generated from the production and distribution of high-performance fibers, films, sheets, engineering plastics, and composite materials to industrial clients.
- Healthcare product sales and services: Income derived from the sale of pharmaceuticals, medical devices, and integrated healthcare systems to hospitals, clinics, and individual patients.
- Information technology solutions: Revenue from the provision of RFID systems and other IT-based engineering solutions for inventory management and industrial efficiency.
- Licensing and intellectual property: Potential income from licensing its proprietary technologies and materials to other manufacturers, though not explicitly detailed in the source.
- Sustainable solutions: Revenue from products and engineering services focused on environmental impact reduction, such as recycled materials and pollution control technologies.
What Industry Does TINLY Operate In?
Teijin Limited operates within the broad Industrials sector, specifically categorized under Conglomerates due to its highly diversified business model spanning advanced materials, healthcare, and information technology. This positioning allows Teijin to tap into multiple market trends simultaneously. In materials, the company benefits from the increasing global demand for high-performance, lightweight solutions in automotive and aerospace, driven by fuel efficiency and sustainability mandates. The healthcare segment capitalizes on an aging global population and rising demand for pharmaceuticals, medical devices, and integrated care systems. While the IT division addresses the ongoing digital transformation in industrial and logistics sectors. Teijin's strategy of diversification aims to mitigate risks associated with cyclicality in any single industry, enabling it to leverage synergies across its technology-driven businesses. The competitive landscape is fragmented, with specialized players in each segment, but Teijin's integrated approach and long history of innovation provide a distinct market presence.
Who Are TINLY's Key Customers?
- Automotive manufacturers utilizing lightweight composites and engineering plastics.
- Aerospace industry for high-performance fibers and advanced materials.
- Healthcare providers, including hospitals, clinics, and home care services, for pharmaceuticals and medical devices.
- Industrial clients across various sectors requiring specialized films, sheets, and IT solutions for inventory.
- Consumers and patients directly benefiting from pharmaceuticals and home medical equipment.
FY2026 estForward Outlook
Wall Street analysts project Teijin Limited revenue of about $875.42B for fiscal 2026, with EPS near $-159.27. The estimate reflects 5 contributing analysts.
F-Score 4/9Financial Health
Teijin Limited's Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 1.49 places it in the distress zone, a signal of elevated financial risk.
ROE -22%Key Financial Metrics
Return on equity for Teijin Limited stands at -22.5%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -9.6%, showing how much profit it generates from its asset base. Its free cash flow yield is 13.6%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.75 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -26.5%, the inverse of the P/E and a quick read on earnings relative to price.
Teijin Limited (TINLY) Valuation Context
Valued at $1.77B, TINLY is classified as a small-cap stock.
Company Profile
Teijin Limited operates in the Conglomerates industry within the Industrials sector. It is headquartered in Tokyo, JP. The company is led by CEO Akimoto Uchikawa. TINLY has traded publicly since 1996.
TINLY Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2026
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in Teijin's strategic direction and potential growth.
- Community sentiment has turned increasingly positive, with discussions highlighting the company's innovative materials and sustainability initiatives.
- Market perception has improved due to recent partnerships in the automotive and healthcare sectors, enhancing Teijin's growth prospects.
- Analysts note that Teijin's diversification into high-demand industries positions it well for future resilience.
Bear Case
- Concerns over global supply chain disruptions could impact Teijin's production capabilities and operational efficiency.
- Despite positive sentiment, some community members express skepticism about the company's ability to maintain profitability amidst rising raw material costs.
- Recent earnings reports indicated challenges in certain segments, leading to doubts about overall performance consistency.
- Market volatility in related sectors raises questions about Teijin's short-term stability and investor confidence.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
TINLY Latest News
No recent news available for TINLY.
TINLY Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for TINLY.
Price Targets
Wall Street price target analysis for TINLY.
TINLY MoonshotScore
What does this score mean?
The MoonshotScore rates TINLY's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Classification
Industry ConglomeratesLeadership: Akimoto Uchikawa
Chief Executive Officer
Information regarding Akimoto Uchikawa's specific career history, education, and previous roles prior to his current position as CEO of Teijin Limited was not provided in the source data. He is noted for managing a global workforce of 21,834 employees, overseeing the company's diverse operations across advanced materials, healthcare, and information technology sectors. His leadership is central to the strategic direction and operational execution of this complex conglomerate.
Track Record: Specific achievements, strategic decisions, or company milestones directly attributable to Akimoto Uchikawa's leadership were not detailed in the provided source data. His role involves steering Teijin Limited's extensive portfolio and ensuring the company's continued innovation and market positioning across its varied business segments, including high-performance materials, healthcare solutions, and IT offerings.
Teijin Limited ADR Information Unsponsored
Teijin Limited trades as an American Depositary Receipt (ADR) Level 1, which means its shares are traded on the U.S. over-the-counter (OTC) market. This structure allows U.S. investors to buy shares of a foreign company without directly trading on its home stock exchange. A Level 1 ADR is the most basic form, typically established by a depositary bank without direct company involvement, facilitating access to the company's existing shares.
- Home Market Ticker: Teijin Limited's primary stock exchange is the Tokyo Stock Exchange in Japan, where its ordinary shares (TINL) are traded.
- ADR Level: 1
- ADR Ratio: 1:1
- Home Market Ticker: TINL
TINLY OTC Market Information
Teijin Limited's ADR (TINLY) trades on the OTC Other tier of the OTC market. This tier represents companies that are current in their reporting with a U.S. regulator or have made information publicly available in English through an international information exchange. However, it is the lowest tier among OTC markets, often characterized by less stringent disclosure requirements compared to OTCQX or OTCQB, and significantly less than major exchanges like NYSE or NASDAQ. This tier is typically associated with lower liquidity and higher risk.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Lower Liquidity: Reduced trading volume and wider bid-ask spreads can make it difficult to enter or exit positions efficiently.
- Limited Disclosure: The 'Unknown' disclosure status implies less transparency, making it harder for investors to access comprehensive and timely financial information.
- Price Volatility: Lower liquidity and less oversight can contribute to greater price fluctuations and potentially more speculative trading.
- Less Regulatory Oversight: OTC markets, particularly lower tiers, generally have less stringent regulatory requirements compared to major stock exchanges.
- Information Asymmetry: Investors may have less access to critical company information compared to those trading on the home market or major U.S. exchanges.
- Verify any available financial reports, even if disclosure status is unknown, directly from the company's investor relations or home country filings.
- Research recent company news and press releases from both U.S. and Japanese sources to gauge operational developments.
- Analyze trading volume and bid-ask spreads to assess liquidity and potential trading costs.
- Understand the company's business model and market position thoroughly, given the diversified nature of Teijin Limited.
- Assess the impact of currency exchange rates (JPY/USD) on the ADR's value and dividend payments.
- Consult with a tax advisor regarding the implications of Japanese withholding tax on dividends.
- Established Company: Founded in 1918, Teijin Limited has a long operating history, indicating stability and experience.
- Global Operations: The company is a global enterprise with a significant international presence, suggesting a robust business structure.
- Large Workforce: Employing 21,834 individuals, Teijin demonstrates substantial operational scale and commitment.
- Diversified Portfolio: Its involvement in advanced materials, healthcare, and IT signifies a broad and technology-driven business.
- Headquartered in Tokyo, Japan: A major economic hub, indicating a structured corporate environment.
Common Questions About TINLY (Industrials)
What is Teijin Limited's core business strategy and product portfolio?
Teijin Limited's core business strategy revolves around leveraging its advanced material science expertise and technological innovation across three main segments: advanced materials, healthcare, and information technology. In materials, it focuses on high-performance fibers like aramid and carbon, engineering plastics, and composites for automotive and industrial uses. The healthcare segment offers pharmaceuticals for chronic diseases and a range of medical devices, including home oxygen therapy and rehabilitation aids. Its IT division provides solutions such as RFID for inventory management. This diversified portfolio aims to capitalize on global trends like lightweighting, an aging population, and digital transformation, while mitigating risks across various market cycles.
How does Teijin Limited manage its diversified operations across materials, healthcare, and IT?
Teijin Limited manages its diversified operations by fostering technological synergies and shared expertise across its materials, healthcare, and IT segments. While each segment operates with specialized product development and market strategies, there's an overarching corporate commitment to innovation and addressing global challenges like environmental sustainability and an aging society. This integrated approach allows the company to leverage its R&D capabilities in material science for applications in healthcare devices or to apply IT solutions to optimize material production and logistics. The conglomerate structure provides a broad base for revenue generation and risk mitigation, balancing cyclical industrial demands with more stable healthcare needs.
What are the specific risks associated with investing in Teijin Limited's ADR on the OTC market?
Investing in Teijin Limited's ADR on the OTC market carries several specific risks. As an OTC Other listed stock, it typically experiences lower liquidity compared to major exchange-listed securities, leading to wider bid-ask spreads and potential difficulty in executing trades at desired prices. The 'Unknown' disclosure status implies less transparency, making it challenging for investors to access comprehensive and timely financial information. Furthermore, ADR holders are exposed to currency risk, as fluctuations between the Japanese Yen and the U.S. Dollar can impact the dollar-denominated value of the investment and dividends. The OTC market also generally has less regulatory oversight, which can contribute to higher price volatility and less investor protection.
How does Teijin Limited contribute to addressing global environmental and societal challenges?
Teijin Limited is actively committed to addressing global environmental and societal challenges through its product development and engineering solutions. In the environmental sphere, the company focuses on sustainable materials, such as recycled polyester fibers, and develops engineering solutions aimed at mitigating environmental pollution and ensuring stable energy supplies. This aligns with global efforts towards a circular economy and reduced carbon footprints. Societally, its healthcare segment provides crucial pharmaceuticals and medical devices, including home oxygen therapy and systems for sleep-disordered breathing, directly contributing to improving quality of life and managing the impacts of an aging workforce and population. These initiatives are integral to Teijin's long-term corporate strategy.
What are the key financial metrics investors may want to evaluate when evaluating Teijin Limited?
When evaluating Teijin Limited, investors may want to evaluate several key financial metrics given its diversified industrial conglomerate nature. The negative profit margin of -10.1% is a critical indicator of current profitability challenges, warranting close scrutiny of operational efficiency and cost management. Conversely, the gross margin of 18.5% provides insight into the company's core manufacturing profitability before operating expenses. The market capitalization of $1.77B positions it as a mid-cap company. Its Beta of 0.30 suggests lower volatility relative to the broader market. Additionally, the 3.05% dividend yield is relevant for income-focused investors, though its sustainability should be assessed in light of the negative profit margin. Given its ADR status, currency exchange rate impacts on reported financials are also crucial.
What are the key factors to evaluate for TINLY?
Evaluate TINLY on fundamentals, analyst consensus, and risk factors. Not financial advice.
How frequently does TINLY data refresh on this page?
TINLY prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven TINLY's recent stock price performance?
Teijin Limited (TINLY) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Highly diversified business portfolio across advanced materials, healthcare, and IT, providing resilience. See the News tab for the latest drivers. Past performance does not predict future results.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- No FMP PEER TICKERS were provided, so competitor information is limited to a placeholder.
- Specific details on CEO's background and track record were not provided in the source data.
- Disclosure status for OTC market is explicitly stated as 'Unknown' in the source data.
- Specific tax treaty details and exact foreign dividend withholding tax rates were not provided, general information used.